SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001445305-13-002987
Filing Date
2013-11-12
Accepted
2013-11-12 17:05:04
Documents
3
Period of Report
2013-11-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a8-kq3earningsrelease.htm 8-K 20861
2 EX-99.1 ljpvq3finresultscorpprogre.htm EX-99.1 100829
3 ljpcpressrelease_image1.jpg GRAPHIC 21134
  Complete submission text file 0001445305-13-002987.txt   152056
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 131211215
SIC: 2836 Biological Products, (No Diagnostic Substances)